<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;ff=20231001160737&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.17.9.post6+86293ac
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;ff=20231001160737&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.17.9.post6+86293ac" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Sun, 01 Oct 2023 20:07:40 +0000</lastbuilddate>
<pubDate>Sun, 01 Oct 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Understanding T2MI: Thank Goodness for the Women</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37777948/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Sep 18:S0735-1097(23)06470-7. doi: 10.1016/j.jacc.2023.08.021. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37777948/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37777948</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.021>10.1016/j.jacc.2023.08.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37777948</guid>
<pubDate>Sun, 01 Oct 2023 06:00:00 -0400</pubDate>
<dc:creator>C Noel Bairey Merz</dc:creator>
<dc:creator>Martha Gulati</dc:creator>
<dc:creator>Janet Wei</dc:creator>
<dc:date>2023-10-01</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Understanding T2MI: Thank Goodness for the Women</dc:title>
<dc:identifier>pmid:37777948</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.021</dc:identifier>
</item>
<item>
<title>Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial Infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37777947/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Among individuals with adjudicated T2MI, CAD was prevalent, but the majority of patients had nonobstructive CAD. Mediators of ischemia are likely multifactorial in this population. (Defining the Prevalence and Characteristics of Coronary Artery Disease Among Patients with Type 2 Myocardial Infarction using CT-FFR [DEFINE TYPE 2 MI]; NCT04864119).</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Sep 18:S0735-1097(23)06469-0. doi: 10.1016/j.jacc.2023.08.020. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Type 2 myocardial infarction (T2MI) related to a supply/demand imbalance of coronary blood flow is common and associated with poor prognosis. Coronary artery disease (CAD) may predispose some individuals to T2MI and contribute to its high rate of recurrent cardiovascular events. Little is known about the presence and extent of CAD in this population.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The goal of this study was to evaluate the presence and characteristics of CAD among patients with T2MI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this prospective study, consecutive eligible individuals with Fourth Universal Definition of Myocardial Infarction criteria for T2MI were enrolled. Participants underwent coronary computed tomography angiography (CTA), fractional flow reserve derived with coronary CTA (FFR<sub>CT</sub>), and plaque volume analyses.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 50 participants, 25 (50%) were female, and the mean age was 68.0 ± 11.4 years. Atherosclerotic risk factors were common. Coronary CTA revealed coronary plaque in 46 participants (92%). A moderate or greater stenosis (≥50%) was identified in 42% of participants, and obstructive disease (≥50% left main stenosis or ≥70% stenosis in any other epicardial coronary artery) was present in 26%. Prevalence of obstructive CAD did not differ according to T2MI cause (P = 0.54). A hemodynamically significant focal stenosis identified by FFR<sub>CT</sub> was present in 13 participants (26%). Among participants with a stenosis ≥50% (n = 21), FFR<sub>CT</sub> excluded lesion-specific hemodynamically significant stenosis in 8 cases (38%).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Among individuals with adjudicated T2MI, CAD was prevalent, but the majority of patients had nonobstructive CAD. Mediators of ischemia are likely multifactorial in this population. (Defining the Prevalence and Characteristics of Coronary Artery Disease Among Patients with Type 2 Myocardial Infarction using CT-FFR [DEFINE TYPE 2 MI]; NCT04864119).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37777947/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37777947</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.020>10.1016/j.jacc.2023.08.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37777947</guid>
<pubDate>Sun, 01 Oct 2023 06:00:00 -0400</pubDate>
<dc:creator>Cian P McCarthy</dc:creator>
<dc:creator>Sean P Murphy</dc:creator>
<dc:creator>Daniel K Amponsah</dc:creator>
<dc:creator>Paula K Rambarat</dc:creator>
<dc:creator>Claire Lin</dc:creator>
<dc:creator>Yuxi Liu</dc:creator>
<dc:creator>Reza Mohebi</dc:creator>
<dc:creator>Allison Levin</dc:creator>
<dc:creator>Avanthi Raghavan</dc:creator>
<dc:creator>Hannah Miksenas</dc:creator>
<dc:creator>Campbell Rogers</dc:creator>
<dc:creator>Jason H Wasfy</dc:creator>
<dc:creator>Ron Blankstein</dc:creator>
<dc:creator>Brian Ghoshhajra</dc:creator>
<dc:creator>Sandeep Hedgire</dc:creator>
<dc:creator>James L Januzzi</dc:creator>
<dc:date>2023-10-01</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial Infarction</dc:title>
<dc:identifier>pmid:37777947</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.020</dc:identifier>
</item>
<item>
<title>An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37776859/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>SpCas9 and AsCas12a are widely utilized as genome-editing tools in human cells. However, their relatively large size poses a limitation for delivery by cargo-size-limited adeno-associated virus (AAV) vectors. The type V-F Cas12f from Acidibacillus sulfuroxidans is exceptionally compact (422 amino acids) and has been harnessed as a compact genome-editing tool. Here, we developed an approach, combining deep mutational scanning and structure-informed design, to successfully generate two AsCas12f...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 22:S0092-8674(23)00963-7. doi: 10.1016/j.cell.2023.08.031. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SpCas9 and AsCas12a are widely utilized as genome-editing tools in human cells. However, their relatively large size poses a limitation for delivery by cargo-size-limited adeno-associated virus (AAV) vectors. The type V-F Cas12f from Acidibacillus sulfuroxidans is exceptionally compact (422 amino acids) and has been harnessed as a compact genome-editing tool. Here, we developed an approach, combining deep mutational scanning and structure-informed design, to successfully generate two AsCas12f activity-enhanced (enAsCas12f) variants. Remarkably, the enAsCas12f variants exhibited genome-editing activities in human cells comparable with those of SpCas9 and AsCas12a. The cryoelectron microscopy (cryo-EM) structures revealed that the mutations stabilize the dimer formation and reinforce interactions with nucleic acids to enhance their DNA cleavage activities. Moreover, enAsCas12f packaged with partner genes in an all-in-one AAV vector exhibited efficient knock-in/knock-out activities and transcriptional activation in mice. Taken together, enAsCas12f variants could offer a minimal genome-editing platform for in vivo gene therapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37776859/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37776859</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.031>10.1016/j.cell.2023.08.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37776859</guid>
<pubDate>Sat, 30 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Tomohiro Hino</dc:creator>
<dc:creator>Satoshi N Omura</dc:creator>
<dc:creator>Ryoya Nakagawa</dc:creator>
<dc:creator>Tomoki Togashi</dc:creator>
<dc:creator>Satoru N Takeda</dc:creator>
<dc:creator>Takafumi Hiramoto</dc:creator>
<dc:creator>Satoshi Tasaka</dc:creator>
<dc:creator>Hisato Hirano</dc:creator>
<dc:creator>Takeshi Tokuyama</dc:creator>
<dc:creator>Hideki Uosaki</dc:creator>
<dc:creator>Soh Ishiguro</dc:creator>
<dc:creator>Madina Kagieva</dc:creator>
<dc:creator>Hiroyuki Yamano</dc:creator>
<dc:creator>Yuki Ozaki</dc:creator>
<dc:creator>Daisuke Motooka</dc:creator>
<dc:creator>Hideto Mori</dc:creator>
<dc:creator>Yuhei Kirita</dc:creator>
<dc:creator>Yoshiaki Kise</dc:creator>
<dc:creator>Yuzuru Itoh</dc:creator>
<dc:creator>Satoaki Matoba</dc:creator>
<dc:creator>Hiroyuki Aburatani</dc:creator>
<dc:creator>Nozomu Yachie</dc:creator>
<dc:creator>Tautvydas Karvelis</dc:creator>
<dc:creator>Virginijus Siksnys</dc:creator>
<dc:creator>Tsukasa Ohmori</dc:creator>
<dc:creator>Atsushi Hoshino</dc:creator>
<dc:creator>Osamu Nureki</dc:creator>
<dc:date>2023-09-30</dc:date>
<dc:source>Cell</dc:source>
<dc:title>An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis</dc:title>
<dc:identifier>pmid:37776859</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.031</dc:identifier>
</item>
<item>
<title>Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37776858/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>The dynamics of immunity to infection in infants remain obscure. Here, we used a multi-omics approach to perform a longitudinal analysis of immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in infants and young children by analyzing blood samples and weekly nasal swabs collected before, during, and after infection with Omicron and non-Omicron variants. Infection stimulated robust antibody titers that, unlike in adults, showed no sign of decay for up to 300 days. Infants...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 26:S0092-8674(23)00978-9. doi: 10.1016/j.cell.2023.08.044. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The dynamics of immunity to infection in infants remain obscure. Here, we used a multi-omics approach to perform a longitudinal analysis of immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in infants and young children by analyzing blood samples and weekly nasal swabs collected before, during, and after infection with Omicron and non-Omicron variants. Infection stimulated robust antibody titers that, unlike in adults, showed no sign of decay for up to 300 days. Infants mounted a robust mucosal immune response characterized by inflammatory cytokines, interferon (IFN) α, and T helper (Th) 17 and neutrophil markers (interleukin [IL]-17, IL-8, and CXCL1). The immune response in blood was characterized by upregulation of activation markers on innate cells, no inflammatory cytokines, but several chemokines and IFNα. The latter correlated with viral load and expression of interferon-stimulated genes (ISGs) in myeloid cells measured by single-cell multi-omics. Together, these data provide a snapshot of immunity to infection during the initial weeks and months of life.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37776858/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37776858</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.044>10.1016/j.cell.2023.08.044</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37776858</guid>
<pubDate>Sat, 30 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Florian Wimmers</dc:creator>
<dc:creator>Allison R Burrell</dc:creator>
<dc:creator>Yupeng Feng</dc:creator>
<dc:creator>Hong Zheng</dc:creator>
<dc:creator>Prabhu S Arunachalam</dc:creator>
<dc:creator>Mengyun Hu</dc:creator>
<dc:creator>Sara Spranger</dc:creator>
<dc:creator>Lindsay E Nyhoff</dc:creator>
<dc:creator>Devyani Joshi</dc:creator>
<dc:creator>Meera Trisal</dc:creator>
<dc:creator>Mayanka Awasthi</dc:creator>
<dc:creator>Lorenza Bellusci</dc:creator>
<dc:creator>Usama Ashraf</dc:creator>
<dc:creator>Sangeeta Kowli</dc:creator>
<dc:creator>Katherine C Konvinse</dc:creator>
<dc:creator>Emily Yang</dc:creator>
<dc:creator>Michael Blanco</dc:creator>
<dc:creator>Kathryn Pellegrini</dc:creator>
<dc:creator>Gregory Tharp</dc:creator>
<dc:creator>Thomas Hagan</dc:creator>
<dc:creator>R Sharon Chinthrajah</dc:creator>
<dc:creator>Tran T Nguyen</dc:creator>
<dc:creator>Alba Grifoni</dc:creator>
<dc:creator>Alessandro Sette</dc:creator>
<dc:creator>Kari C Nadeau</dc:creator>
<dc:creator>David B Haslam</dc:creator>
<dc:creator>Steven E Bosinger</dc:creator>
<dc:creator>Jens Wrammert</dc:creator>
<dc:creator>Holden T Maecker</dc:creator>
<dc:creator>Paul J Utz</dc:creator>
<dc:creator>Taia T Wang</dc:creator>
<dc:creator>Surender Khurana</dc:creator>
<dc:creator>Purvesh Khatri</dc:creator>
<dc:creator>Mary A Staat</dc:creator>
<dc:creator>Bali Pulendran</dc:creator>
<dc:date>2023-09-30</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth</dc:title>
<dc:identifier>pmid:37776858</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.044</dc:identifier>
</item>
<item>
<title>Sex-specific and ethnicity-specific differences in MINOCA</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37775559/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Suspected myocardial infarction with non-obstructive coronary arteries (MINOCA) has received increasing attention over the past decade. Given the heterogeneity in the mechanisms underlying acute myocardial infarction in the absence of obstructive coronary arteries, the syndrome of MINOCA is considered a working diagnosis that requires further investigation after diagnostic angiography studies have been performed, including coronary magnetic resonance angiography and functional angiography....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2023 Sep 29. doi: 10.1038/s41569-023-00927-6. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Suspected myocardial infarction with non-obstructive coronary arteries (MINOCA) has received increasing attention over the past decade. Given the heterogeneity in the mechanisms underlying acute myocardial infarction in the absence of obstructive coronary arteries, the syndrome of MINOCA is considered a working diagnosis that requires further investigation after diagnostic angiography studies have been performed, including coronary magnetic resonance angiography and functional angiography. Although once considered an infrequent and low-risk form of myocardial infarction, recent data have shown that the prognosis of MINOCA is not as benign as previously assumed. However, despite increasing awareness of the condition, many questions remain regarding the diagnosis, risk stratification and treatment of MINOCA. Women seem to be more susceptible to MINOCA, but studies on the sex-specific differences of the disease are scarce. Similarly, ethnicity-specific factors might explain discrepancies in the observed prevalence or underlying pathophysiological mechanisms of MINOCA but data are also scarce. Therefore, in this Review, we provide an update on the latest evidence available on the sex-specific and ethnicity-specific differences in the clinical features, pathophysiological mechanisms, treatment and prognosis of MINOCA.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37775559/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37775559</a> | DOI:<a href=https://doi.org/10.1038/s41569-023-00927-6>10.1038/s41569-023-00927-6</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37775559</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Sarena La</dc:creator>
<dc:creator>John Beltrame</dc:creator>
<dc:creator>Rosanna Tavella</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Sex-specific and ethnicity-specific differences in MINOCA</dc:title>
<dc:identifier>pmid:37775559</dc:identifier>
<dc:identifier>doi:10.1038/s41569-023-00927-6</dc:identifier>
</item>
<item>
<title>Synthetic Par polarity induces cytoskeleton asymmetry in unpolarized mammalian cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774705/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Polarized cells rely on a polarized cytoskeleton to function. Yet, how cortical polarity cues induce cytoskeleton polarization remains elusive. Here, we capitalized on recently established designed 2D protein arrays to ectopically engineer cortical polarity of virtually any protein of interest during mitosis in various cell types. This enables direct manipulation of polarity signaling and the identification of the cortical cues sufficient for cytoskeleton polarization. Using this assay, we...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 20:S0092-8674(23)00968-6. doi: 10.1016/j.cell.2023.08.034. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Polarized cells rely on a polarized cytoskeleton to function. Yet, how cortical polarity cues induce cytoskeleton polarization remains elusive. Here, we capitalized on recently established designed 2D protein arrays to ectopically engineer cortical polarity of virtually any protein of interest during mitosis in various cell types. This enables direct manipulation of polarity signaling and the identification of the cortical cues sufficient for cytoskeleton polarization. Using this assay, we dissected the logic of the Par complex pathway, a key regulator of cytoskeleton polarity during asymmetric cell division. We show that cortical clustering of any Par complex subunit is sufficient to trigger complex assembly and that the primary kinetic barrier to complex assembly is the relief of Par6 autoinhibition. Further, we found that inducing cortical Par complex polarity induces two hallmarks of asymmetric cell division in unpolarized mammalian cells: spindle orientation, occurring via Par3, and central spindle asymmetry, depending on aPKC activity.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774705/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774705</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.034>10.1016/j.cell.2023.08.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774705</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Joseph L Watson</dc:creator>
<dc:creator>Lara K Krüger</dc:creator>
<dc:creator>Ariel J Ben-Sasson</dc:creator>
<dc:creator>Alice Bittleston</dc:creator>
<dc:creator>Marta N Shahbazi</dc:creator>
<dc:creator>Vicente Jose Planelles-Herrero</dc:creator>
<dc:creator>Joseph E Chambers</dc:creator>
<dc:creator>James D Manton</dc:creator>
<dc:creator>David Baker</dc:creator>
<dc:creator>Emmanuel Derivery</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Synthetic Par polarity induces cytoskeleton asymmetry in unpolarized mammalian cells</dc:title>
<dc:identifier>pmid:37774705</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.034</dc:identifier>
</item>
<item>
<title>A widely distributed gene cluster compensates for uricase loss in hominids</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774682/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 28;186(20):4472-4473. doi: 10.1016/j.cell.2023.08.036.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774682/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774682</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.036>10.1016/j.cell.2023.08.036</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774682</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Yuanyuan Liu</dc:creator>
<dc:creator>J Bryce Jarman</dc:creator>
<dc:creator>Yen S Low</dc:creator>
<dc:creator>Hannah E Augustijn</dc:creator>
<dc:creator>Steven Huang</dc:creator>
<dc:creator>Haoqing Chen</dc:creator>
<dc:creator>Mary E DeFeo</dc:creator>
<dc:creator>Kazuma Sekiba</dc:creator>
<dc:creator>Bi-Huei Hou</dc:creator>
<dc:creator>Xiandong Meng</dc:creator>
<dc:creator>Allison M Weakley</dc:creator>
<dc:creator>Ashley V Cabrera</dc:creator>
<dc:creator>Zhiwei Zhou</dc:creator>
<dc:creator>Gilles van Wezel</dc:creator>
<dc:creator>Marnix H Medema</dc:creator>
<dc:creator>Calyani Ganesan</dc:creator>
<dc:creator>Alan C Pao</dc:creator>
<dc:creator>Saurabh Gombar</dc:creator>
<dc:creator>Dylan Dodd</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A widely distributed gene cluster compensates for uricase loss in hominids</dc:title>
<dc:identifier>pmid:37774682</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.036</dc:identifier>
</item>
<item>
<title>Early Alzheimer's disease pathology in human cortex involves transient cell states</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774681/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Cellular perturbations underlying Alzheimer's disease (AD) are primarily studied in human postmortem samples and model organisms. Here, we generated a single-nucleus atlas from a rare cohort of cortical biopsies from living individuals with varying degrees of AD pathology. We next performed a systematic cross-disease and cross-species integrative analysis to identify a set of cell states that are specific to early AD pathology. These changes-which we refer to as the early cortical amyloid...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 28;186(20):4438-4453.e23. doi: 10.1016/j.cell.2023.08.005.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cellular perturbations underlying Alzheimer's disease (AD) are primarily studied in human postmortem samples and model organisms. Here, we generated a single-nucleus atlas from a rare cohort of cortical biopsies from living individuals with varying degrees of AD pathology. We next performed a systematic cross-disease and cross-species integrative analysis to identify a set of cell states that are specific to early AD pathology. These changes-which we refer to as the early cortical amyloid response-were prominent in neurons, wherein we identified a transitional hyperactive state preceding the loss of excitatory neurons, which we confirmed by acute slice physiology on independent biopsy specimens. Microglia overexpressing neuroinflammatory-related processes also expanded as AD pathology increased. Finally, both oligodendrocytes and pyramidal neurons upregulated genes associated with β-amyloid production and processing during this early hyperactive phase. Our integrative analysis provides an organizing framework for targeting circuit dysfunction, neuroinflammation, and amyloid production early in AD pathogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774681/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774681</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.005>10.1016/j.cell.2023.08.005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774681</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Vahid Gazestani</dc:creator>
<dc:creator>Tushar Kamath</dc:creator>
<dc:creator>Naeem M Nadaf</dc:creator>
<dc:creator>Antonios Dougalis</dc:creator>
<dc:creator>S J Burris</dc:creator>
<dc:creator>Brendan Rooney</dc:creator>
<dc:creator>Antti Junkkari</dc:creator>
<dc:creator>Charles Vanderburg</dc:creator>
<dc:creator>Anssi Pelkonen</dc:creator>
<dc:creator>Mireia Gomez-Budia</dc:creator>
<dc:creator>Nelli-Noora Välimäki</dc:creator>
<dc:creator>Tuomas Rauramaa</dc:creator>
<dc:creator>Martine Therrien</dc:creator>
<dc:creator>Anne M Koivisto</dc:creator>
<dc:creator>Matthew Tegtmeyer</dc:creator>
<dc:creator>Sanna-Kaisa Herukka</dc:creator>
<dc:creator>Abdulraouf Abdulraouf</dc:creator>
<dc:creator>Samuel E Marsh</dc:creator>
<dc:creator>Mikko Hiltunen</dc:creator>
<dc:creator>Ralda Nehme</dc:creator>
<dc:creator>Tarja Malm</dc:creator>
<dc:creator>Beth Stevens</dc:creator>
<dc:creator>Ville Leinonen</dc:creator>
<dc:creator>Evan Z Macosko</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Early Alzheimer's disease pathology in human cortex involves transient cell states</dc:title>
<dc:identifier>pmid:37774681</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.005</dc:identifier>
</item>
<item>
<title>Epigenomic dissection of Alzheimer's disease pinpoints causal variants and reveals epigenome erosion</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774680/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Recent work has identified dozens of non-coding loci for Alzheimer's disease (AD) risk, but their mechanisms and AD transcriptional regulatory circuitry are poorly understood. Here, we profile epigenomic and transcriptomic landscapes of 850,000 nuclei from prefrontal cortexes of 92 individuals with and without AD to build a map of the brain regulome, including epigenomic profiles, transcriptional regulators, co-accessibility modules, and peak-to-gene links in a cell-type-specific manner. We...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 28;186(20):4422-4437.e21. doi: 10.1016/j.cell.2023.08.040.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Recent work has identified dozens of non-coding loci for Alzheimer's disease (AD) risk, but their mechanisms and AD transcriptional regulatory circuitry are poorly understood. Here, we profile epigenomic and transcriptomic landscapes of 850,000 nuclei from prefrontal cortexes of 92 individuals with and without AD to build a map of the brain regulome, including epigenomic profiles, transcriptional regulators, co-accessibility modules, and peak-to-gene links in a cell-type-specific manner. We develop methods for multimodal integration and detecting regulatory modules using peak-to-gene linking. We show AD risk loci are enriched in microglial enhancers and for specific TFs including SPI1, ELF2, and RUNX1. We detect 9,628 cell-type-specific ATAC-QTL loci, which we integrate alongside peak-to-gene links to prioritize AD variant regulatory circuits. We report differential accessibility of regulatory modules in late AD in glia and in early AD in neurons. Strikingly, late-stage AD brains show global epigenome dysregulation indicative of epigenome erosion and cell identity loss.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774680/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774680</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.040>10.1016/j.cell.2023.08.040</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774680</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Xushen Xiong</dc:creator>
<dc:creator>Benjamin T James</dc:creator>
<dc:creator>Carles A Boix</dc:creator>
<dc:creator>Yongjin P Park</dc:creator>
<dc:creator>Kyriaki Galani</dc:creator>
<dc:creator>Matheus B Victor</dc:creator>
<dc:creator>Na Sun</dc:creator>
<dc:creator>Lei Hou</dc:creator>
<dc:creator>Li-Lun Ho</dc:creator>
<dc:creator>Julio Mantero</dc:creator>
<dc:creator>Aine Ni Scannail</dc:creator>
<dc:creator>Vishnu Dileep</dc:creator>
<dc:creator>Weixiu Dong</dc:creator>
<dc:creator>Hansruedi Mathys</dc:creator>
<dc:creator>David A Bennett</dc:creator>
<dc:creator>Li-Huei Tsai</dc:creator>
<dc:creator>Manolis Kellis</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Epigenomic dissection of Alzheimer's disease pinpoints causal variants and reveals epigenome erosion</dc:title>
<dc:identifier>pmid:37774680</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.040</dc:identifier>
</item>
<item>
<title>Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774679/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Persistent DNA double-strand breaks (DSBs) in neurons are an early pathological hallmark of neurodegenerative diseases including Alzheimer's disease (AD), with the potential to disrupt genome integrity. We used single-nucleus RNA-seq in human postmortem prefrontal cortex samples and found that excitatory neurons in AD were enriched for somatic mosaic gene fusions. Gene fusions were particularly enriched in excitatory neurons with DNA damage repair and senescence gene signatures. In addition,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 28;186(20):4404-4421.e20. doi: 10.1016/j.cell.2023.08.038.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Persistent DNA double-strand breaks (DSBs) in neurons are an early pathological hallmark of neurodegenerative diseases including Alzheimer's disease (AD), with the potential to disrupt genome integrity. We used single-nucleus RNA-seq in human postmortem prefrontal cortex samples and found that excitatory neurons in AD were enriched for somatic mosaic gene fusions. Gene fusions were particularly enriched in excitatory neurons with DNA damage repair and senescence gene signatures. In addition, somatic genome structural variations and gene fusions were enriched in neurons burdened with DSBs in the CK-p25 mouse model of neurodegeneration. Neurons enriched for DSBs also had elevated levels of cohesin along with progressive multiscale disruption of the 3D genome organization aligned with transcriptional changes in synaptic, neuronal development, and histone genes. Overall, this study demonstrates the disruption of genome stability and the 3D genome organization by DSBs in neurons as pathological steps in the progression of neurodegenerative diseases.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774679/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774679</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.038>10.1016/j.cell.2023.08.038</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774679</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Vishnu Dileep</dc:creator>
<dc:creator>Carles A Boix</dc:creator>
<dc:creator>Hansruedi Mathys</dc:creator>
<dc:creator>Asaf Marco</dc:creator>
<dc:creator>Gwyneth M Welch</dc:creator>
<dc:creator>Hiruy S Meharena</dc:creator>
<dc:creator>Anjanet Loon</dc:creator>
<dc:creator>Ritika Jeloka</dc:creator>
<dc:creator>Zhuyu Peng</dc:creator>
<dc:creator>David A Bennett</dc:creator>
<dc:creator>Manolis Kellis</dc:creator>
<dc:creator>Li-Huei Tsai</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration</dc:title>
<dc:identifier>pmid:37774679</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.038</dc:identifier>
</item>
<item>
<title>Human microglial state dynamics in Alzheimer's disease progression</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774678/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Altered microglial states affect neuroinflammation, neurodegeneration, and disease but remain poorly understood. Here, we report 194,000 single-nucleus microglial transcriptomes and epigenomes across 443 human subjects and diverse Alzheimer's disease (AD) pathological phenotypes. We annotate 12 microglial transcriptional states, including AD-dysregulated homeostatic, inflammatory, and lipid-processing states. We identify 1,542 AD-differentially-expressed genes, including both...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 28;186(20):4386-4403.e29. doi: 10.1016/j.cell.2023.08.037.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Altered microglial states affect neuroinflammation, neurodegeneration, and disease but remain poorly understood. Here, we report 194,000 single-nucleus microglial transcriptomes and epigenomes across 443 human subjects and diverse Alzheimer's disease (AD) pathological phenotypes. We annotate 12 microglial transcriptional states, including AD-dysregulated homeostatic, inflammatory, and lipid-processing states. We identify 1,542 AD-differentially-expressed genes, including both microglia-state-specific and disease-stage-specific alterations. By integrating epigenomic, transcriptomic, and motif information, we infer upstream regulators of microglial cell states, gene-regulatory networks, enhancer-gene links, and transcription-factor-driven microglial state transitions. We demonstrate that ectopic expression of our predicted homeostatic-state activators induces homeostatic features in human iPSC-derived microglia-like cells, while inhibiting activators of inflammation can block inflammatory progression. Lastly, we pinpoint the expression of AD-risk genes in microglial states and differential expression of AD-risk genes and their regulators during AD progression. Overall, we provide insights underlying microglial states, including state-specific and AD-stage-specific microglial alterations at unprecedented resolution.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774678/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774678</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.037>10.1016/j.cell.2023.08.037</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774678</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Na Sun</dc:creator>
<dc:creator>Matheus B Victor</dc:creator>
<dc:creator>Yongjin P Park</dc:creator>
<dc:creator>Xushen Xiong</dc:creator>
<dc:creator>Aine Ni Scannail</dc:creator>
<dc:creator>Noelle Leary</dc:creator>
<dc:creator>Shaniah Prosper</dc:creator>
<dc:creator>Soujanya Viswanathan</dc:creator>
<dc:creator>Xochitl Luna</dc:creator>
<dc:creator>Carles A Boix</dc:creator>
<dc:creator>Benjamin T James</dc:creator>
<dc:creator>Yosuke Tanigawa</dc:creator>
<dc:creator>Kyriaki Galani</dc:creator>
<dc:creator>Hansruedi Mathys</dc:creator>
<dc:creator>Xueqiao Jiang</dc:creator>
<dc:creator>Ayesha P Ng</dc:creator>
<dc:creator>David A Bennett</dc:creator>
<dc:creator>Li-Huei Tsai</dc:creator>
<dc:creator>Manolis Kellis</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Human microglial state dynamics in Alzheimer's disease progression</dc:title>
<dc:identifier>pmid:37774678</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.037</dc:identifier>
</item>
<item>
<title>Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer's disease pathology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774677/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Alzheimer's disease (AD) is the most common cause of dementia worldwide, but the molecular and cellular mechanisms underlying cognitive impairment remain poorly understood. To address this, we generated a single-cell transcriptomic atlas of the aged human prefrontal cortex covering 2.3 million cells from postmortem human brain samples of 427 individuals with varying degrees of AD pathology and cognitive impairment. Our analyses identified AD-pathology-associated alterations shared between...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 28;186(20):4365-4385.e27. doi: 10.1016/j.cell.2023.08.039.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Alzheimer's disease (AD) is the most common cause of dementia worldwide, but the molecular and cellular mechanisms underlying cognitive impairment remain poorly understood. To address this, we generated a single-cell transcriptomic atlas of the aged human prefrontal cortex covering 2.3 million cells from postmortem human brain samples of 427 individuals with varying degrees of AD pathology and cognitive impairment. Our analyses identified AD-pathology-associated alterations shared between excitatory neuron subtypes, revealed a coordinated increase of the cohesin complex and DNA damage response factors in excitatory neurons and in oligodendrocytes, and uncovered genes and pathways associated with high cognitive function, dementia, and resilience to AD pathology. Furthermore, we identified selectively vulnerable somatostatin inhibitory neuron subtypes depleted in AD, discovered two distinct groups of inhibitory neurons that were more abundant in individuals with preserved high cognitive function late in life, and uncovered a link between inhibitory neurons and resilience to AD pathology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774677/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774677</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.039>10.1016/j.cell.2023.08.039</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774677</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Hansruedi Mathys</dc:creator>
<dc:creator>Zhuyu Peng</dc:creator>
<dc:creator>Carles A Boix</dc:creator>
<dc:creator>Matheus B Victor</dc:creator>
<dc:creator>Noelle Leary</dc:creator>
<dc:creator>Sudhagar Babu</dc:creator>
<dc:creator>Ghada Abdelhady</dc:creator>
<dc:creator>Xueqiao Jiang</dc:creator>
<dc:creator>Ayesha P Ng</dc:creator>
<dc:creator>Kimia Ghafari</dc:creator>
<dc:creator>Alexander K Kunisky</dc:creator>
<dc:creator>Julio Mantero</dc:creator>
<dc:creator>Kyriaki Galani</dc:creator>
<dc:creator>Vanshika N Lohia</dc:creator>
<dc:creator>Gabrielle E Fortier</dc:creator>
<dc:creator>Yasmine Lotfi</dc:creator>
<dc:creator>Jason Ivey</dc:creator>
<dc:creator>Hannah P Brown</dc:creator>
<dc:creator>Pratham R Patel</dc:creator>
<dc:creator>Nehal Chakraborty</dc:creator>
<dc:creator>Jacob I Beaudway</dc:creator>
<dc:creator>Elizabeth J Imhoff</dc:creator>
<dc:creator>Cameron F Keeler</dc:creator>
<dc:creator>Maren M McChesney</dc:creator>
<dc:creator>Haishal H Patel</dc:creator>
<dc:creator>Sahil P Patel</dc:creator>
<dc:creator>Megan T Thai</dc:creator>
<dc:creator>David A Bennett</dc:creator>
<dc:creator>Manolis Kellis</dc:creator>
<dc:creator>Li-Huei Tsai</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer's disease pathology</dc:title>
<dc:identifier>pmid:37774677</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.039</dc:identifier>
</item>
<item>
<title>Tracking cell-type-specific temporal dynamics in human and mouse brains</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774676/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Progenitor cells are critical in preserving organismal homeostasis, yet their diversity and dynamics in the aged brain remain underexplored. We introduced TrackerSci, a single-cell genomic method that combines newborn cell labeling and combinatorial indexing to characterize the transcriptome and chromatin landscape of proliferating progenitor cells in vivo. Using TrackerSci, we investigated the dynamics of newborn cells in mouse brains across various ages and in a mouse model of Alzheimer's...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 28;186(20):4345-4364.e24. doi: 10.1016/j.cell.2023.08.042.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Progenitor cells are critical in preserving organismal homeostasis, yet their diversity and dynamics in the aged brain remain underexplored. We introduced TrackerSci, a single-cell genomic method that combines newborn cell labeling and combinatorial indexing to characterize the transcriptome and chromatin landscape of proliferating progenitor cells in vivo. Using TrackerSci, we investigated the dynamics of newborn cells in mouse brains across various ages and in a mouse model of Alzheimer's disease. Our dataset revealed diverse progenitor cell types in the brain and their epigenetic signatures. We further quantified aging-associated shifts in cell-type-specific proliferation and differentiation and deciphered the associated molecular programs. Extending our study to the progenitor cells in the aged human brain, we identified conserved genetic signatures across species and pinpointed region-specific cellular dynamics, such as the reduced oligodendrogenesis in the cerebellum. We anticipate that TrackerSci will be broadly applicable to unveil cell-type-specific temporal dynamics in diverse systems.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774676/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774676</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.042>10.1016/j.cell.2023.08.042</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774676</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Ziyu Lu</dc:creator>
<dc:creator>Melissa Zhang</dc:creator>
<dc:creator>Jasper Lee</dc:creator>
<dc:creator>Andras Sziraki</dc:creator>
<dc:creator>Sonya Anderson</dc:creator>
<dc:creator>Zehao Zhang</dc:creator>
<dc:creator>Zihan Xu</dc:creator>
<dc:creator>Weirong Jiang</dc:creator>
<dc:creator>Shaoyu Ge</dc:creator>
<dc:creator>Peter T Nelson</dc:creator>
<dc:creator>Wei Zhou</dc:creator>
<dc:creator>Junyue Cao</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Tracking cell-type-specific temporal dynamics in human and mouse brains</dc:title>
<dc:identifier>pmid:37774676</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.042</dc:identifier>
</item>
<item>
<title>The AD odyssey 2023: Tales of single cell</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774675/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Deciphering cellular changes in Alzheimer's disease (AD) using large cohorts with defined clinical stages is essential for understanding the diverse trajectories of AD progression. In this issue of Cell, five studies harnessed the power of single-nuclei RNA sequencing (snRNA-seq) and single-nuclei ATAC sequencing (snATAC-seq) at unprecedented scale and revealed exciting insights into cell-type-specific mechanisms underlying the progression of AD pathogenesis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 28;186(20):4257-4259. doi: 10.1016/j.cell.2023.09.001.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Deciphering cellular changes in Alzheimer's disease (AD) using large cohorts with defined clinical stages is essential for understanding the diverse trajectories of AD progression. In this issue of Cell, five studies harnessed the power of single-nuclei RNA sequencing (snRNA-seq) and single-nuclei ATAC sequencing (snATAC-seq) at unprecedented scale and revealed exciting insights into cell-type-specific mechanisms underlying the progression of AD pathogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774675/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774675</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.09.001>10.1016/j.cell.2023.09.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774675</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Wenjie Luo</dc:creator>
<dc:creator>Wenhui Qu</dc:creator>
<dc:creator>Li Gan</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The AD odyssey 2023: Tales of single cell</dc:title>
<dc:identifier>pmid:37774675</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.09.001</dc:identifier>
</item>
<item>
<title>An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774363/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093/eurheartj/ehad652. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774363/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37774363</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad652>10.1093/eurheartj/ehad652</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774363</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Shibba Takkar Chhabra</dc:creator>
<dc:creator>Aastha Takkar</dc:creator>
<dc:creator>Rajesh Chand Arya</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'</dc:title>
<dc:identifier>pmid:37774363</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad652</dc:identifier>
</item>
<item>
<title>Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37772419/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: For patients with previous coronary artery bypass grafting, CTCA before ICA leads to reductions in procedure time and contrast-induced nephropathy, with improved patient satisfaction. CTCA before ICA should be considered in this group of patients.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Sep 29. doi: 10.1161/CIRCULATIONAHA.123.064465. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Patients with previous coronary artery bypass grafting often require invasive coronary angiography (ICA). However, for these patients, the procedure is technically more challenging and has a higher risk of complications. Observational studies suggest that computed tomography cardiac angiography (CTCA) may facilitate ICA in this group, but this has not been tested in a randomized controlled trial.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This study was a single-center, open-label randomized controlled trial assessing the benefit of adjunctive CTCA in patients with previous coronary artery bypass grafting referred for ICA. Patients were randomized 1:1 to undergo CTCA before ICA or ICA alone. The co-primary end points were procedural duration of the ICA (defined as the interval between local anesthesia administration for obtaining vascular access and removal of the last catheter), patient satisfaction after ICA using a validated questionnaire, and the incidence of contrast-induced nephropathy. Linear regression was used for procedural duration and patient satisfaction score; contrast-induced nephropathy was analyzed using logistic regression. We applied the Bonferroni correction, with <i>P</i>&lt;0.017 considered significant and 98.33% CIs presented. Secondary end points included incidence of procedural complications and 1-year major adverse cardiac events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Over 3 years, 688 patients were randomized with a median follow-up of 1.0 years. The mean age was 69.8±10.4 years, 108 (15.7%) were women, 402 (58.4%) were White, and there was a high burden of comorbidity (85.3% hypertension and 53.8% diabetes). The median time from coronary artery bypass grafting to angiography was 12.0 years, and there were a median of 3 (interquartile range, 2 to 3) grafts per participant. Procedure duration of the ICA was significantly shorter in the CTCA+ICA group (CTCA+ICA, 18.6±9.5 minutes versus ICA alone, 39.5±16.9 minutes [98.33% CI, -23.5 to -18.4]; <i>P</i>&lt;0.001), alongside improved mean ICA satisfaction scores (1=very good to 5=very poor; -1.1 difference [98.33% CI, -1.2 to -0.9]; <i>P</i>&lt;0.001), and reduced incidence of contrast-induced nephropathy (3.4% versus 27.9%; odds ratio, 0.09 [98.33% CI, 0.04-0.2]; <i>P</i>&lt;0.001). Procedural complications (2.3% versus 10.8%; odds ratio, 0.2 [95% CI, 0.1-0.4]; <i>P</i>&lt;0.001) and 1-year major adverse cardiac events (16.0% versus 29.4%; hazard ratio, 0.4 [95% CI, 0.3-0.6]; <i>P</i>&lt;0.001) were also lower in the CTCA+ICA group.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: For patients with previous coronary artery bypass grafting, CTCA before ICA leads to reductions in procedure time and contrast-induced nephropathy, with improved patient satisfaction. CTCA before ICA should be considered in this group of patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CLINICALTRIALS: gov; Unique identifier: NCT03736018.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37772419/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37772419</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064465>10.1161/CIRCULATIONAHA.123.064465</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37772419</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Daniel A Jones</dc:creator>
<dc:creator>Anne-Marie Beirne</dc:creator>
<dc:creator>Matthew Kelham</dc:creator>
<dc:creator>Krishnaraj S Rathod</dc:creator>
<dc:creator>Mervyn Andiapen</dc:creator>
<dc:creator>Lucinda Wynne</dc:creator>
<dc:creator>Thomas Godec</dc:creator>
<dc:creator>Nasim Forooghi</dc:creator>
<dc:creator>Rohini Ramaseshan</dc:creator>
<dc:creator>James C Moon</dc:creator>
<dc:creator>Ceri Davies</dc:creator>
<dc:creator>Christos V Bourantas</dc:creator>
<dc:creator>Andreas Baumbach</dc:creator>
<dc:creator>Charlotte Manisty</dc:creator>
<dc:creator>Andrew Wragg</dc:creator>
<dc:creator>Amrita Ahluwalia</dc:creator>
<dc:creator>Francesca Pugliese</dc:creator>
<dc:creator>Anthony Mathur</dc:creator>
<dc:creator>BYPASS-CTCA Trial Committees and Investigators</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial</dc:title>
<dc:identifier>pmid:37772419</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064465</dc:identifier>
</item>
<item>
<title>An Anterior Second Heart Field Enhancer Regulates the Gene Regulatory Network of the Cardiac Outflow Tract</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37772400/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Our results using human and mouse models reveal an essential gene regulatory network of the OFT that requires an anterior second heart field enhancer to link GATA6 with NKX2-5-dependent rotation and septation gene programs.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Sep 29. doi: 10.1161/CIRCULATIONAHA.123.065700. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Conotruncal defects due to developmental abnormalities of the outflow tract (OFT) are an important cause of cyanotic congenital heart disease. Dysregulation of transcriptional programs tuned by NKX2-5, GATA6, and TBX1 have been implicated in abnormal OFT morphogenesis. However, there remains no consensus on how these transcriptional programs function in a unified gene regulatory network within the OFT.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We generated mice harboring a 226-nucleotide deletion of a highly conserved cardiac enhancer containing 2 GATA-binding sites located ≈9.4 kb upstream of the transcriptional start site of <i>Nkx2-5</i> (<i>Nkx2-5</i><sup><i>∆enh</i></sup>) using CRISPR-Cas9 gene editing and assessed phenotypes. Cardiac defects in <i>Nkx2-5</i><sup><i>∆enh/∆enh</i></sup> mice were structurally characterized using histology and scanning electron micrography, and physiologically assessed using electrocardiography, echocardiography, and optical mapping. Transcriptome analyses were performed using RNA sequencing and single-cell RNA sequencing data sets. Endogenous GATA6 interaction with and activity on the <i>NKX2-5</i> enhancer was studied using chromatin immunoprecipitation sequencing and transposase-accessible chromatin sequencing in human induced pluripotent stem cell-derived cardiomyocytes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: <i>Nkx2-5</i><sup><i>∆enh/∆enh</i></sup> mice recapitulated cyanotic conotruncal defects seen in patients with <i>NKX2-5, GATA6,</i> and <i>TBX1</i> mutations. <i>Nkx2-5</i><sup><i>∆enh/∆enh</i></sup> mice also exhibited defects in right Purkinje fiber network formation, resulting in right bundle-branch block. Enhancer deletion reduced embryonic <i>Nkx2-5</i> expression selectively in the right ventricle and OFT of mutant hearts, indicating that enhancer activity is localized to the anterior second heart field. Transcriptional profiling of the mutant OFT revealed downregulation of important genes involved in OFT rotation and septation, such as <i>Tbx1, Pitx2,</i> and <i>Sema3c</i>. Endogenous GATA6 interacted with the highly conserved enhancer in human induced pluripotent stem cell-derived cardiomyocytes and in wild-type mouse hearts. We found critical dose dependency of cardiac enhancer accessibility on GATA6 gene dosage in human induced pluripotent stem cell-derived cardiomyocytes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our results using human and mouse models reveal an essential gene regulatory network of the OFT that requires an anterior second heart field enhancer to link GATA6 with NKX2-5-dependent rotation and septation gene programs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37772400/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37772400</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065700>10.1161/CIRCULATIONAHA.123.065700</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37772400</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Naoko Yamaguchi</dc:creator>
<dc:creator>Ernest W Chang</dc:creator>
<dc:creator>Ziyan Lin</dc:creator>
<dc:creator>Akshay Shekhar</dc:creator>
<dc:creator>Lei Bu</dc:creator>
<dc:creator>Alireza Khodadadi-Jamayran</dc:creator>
<dc:creator>Aristotelis Tsirigos</dc:creator>
<dc:creator>Yiyun Cen</dc:creator>
<dc:creator>Colin K L Phoon</dc:creator>
<dc:creator>Ivan P Moskowitz</dc:creator>
<dc:creator>David S Park</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>An Anterior Second Heart Field Enhancer Regulates the Gene Regulatory Network of the Cardiac Outflow Tract</dc:title>
<dc:identifier>pmid:37772400</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065700</dc:identifier>
</item>
<item>
<title>The ESC Working Group on Coronary Pathophysiology and Microcirculation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37772387/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 29:ehad650. doi: 10.1093/eurheartj/ehad650. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37772387/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37772387</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad650>10.1093/eurheartj/ehad650</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37772387</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Teresa Padro</dc:creator>
<dc:creator>Edina Cenko</dc:creator>
<dc:creator>Dimitris Tousoulis</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The ESC Working Group on Coronary Pathophysiology and Microcirculation</dc:title>
<dc:identifier>pmid:37772387</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad650</dc:identifier>
</item>
<item>
<title>Preclinicaltrials.eu: prospective registration of animal studies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769667/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad623. doi: 10.1093/eurheartj/ehad623. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769667/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37769667</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad623>10.1093/eurheartj/ehad623</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769667</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Julia M L Menon</dc:creator>
<dc:creator>Mira van der Naald</dc:creator>
<dc:creator>Steven A J Chamuleau</dc:creator>
<dc:creator>Dirk J Duncker</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Preclinicaltrials.eu: prospective registration of animal studies</dc:title>
<dc:identifier>pmid:37769667</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad623</dc:identifier>
</item>
<item>
<title>Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769658/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>SARS-CoV-2 primary strain-based vaccination exerts a protective effect against Omicron variants-initiated infection, symptom occurrence, and disease severity in a booster-dependent manner. Yet, the underlying mechanisms remain unclear. During the 2022 Omicron outbreak in Shanghai, we enrolled 122 infected adults and 50 uninfected controls who had been unvaccinated or vaccinated with two or three doses of COVID-19 inactive vaccines and performed integrative analysis of 41-plex CyTOF, RNA-seq, and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 20:S0092-8674(23)00964-9. doi: 10.1016/j.cell.2023.08.033. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SARS-CoV-2 primary strain-based vaccination exerts a protective effect against Omicron variants-initiated infection, symptom occurrence, and disease severity in a booster-dependent manner. Yet, the underlying mechanisms remain unclear. During the 2022 Omicron outbreak in Shanghai, we enrolled 122 infected adults and 50 uninfected controls who had been unvaccinated or vaccinated with two or three doses of COVID-19 inactive vaccines and performed integrative analysis of 41-plex CyTOF, RNA-seq, and Olink on their peripheral blood samples. The frequencies of HLA-DR<sup>hi</sup> classical monocytes, non-classical monocytes, and Th1-like Tem tended to increase, whereas the frequency of Treg was reduced by booster vaccine, and they influenced symptom occurrence in a vaccine dose-dependent manner. Intercorrelation and mechanistic analysis suggested that the booster vaccination induced monocytic training, which would prime monocytic activation and maturation rather than differentiating into myeloid-derived suppressive cells upon Omicron infections. Overall, our study provides insights into how booster vaccination elaborates protective immunity across SARS-CoV-2 variants.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769658/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37769658</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.033>10.1016/j.cell.2023.08.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769658</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Shanhe Yu</dc:creator>
<dc:creator>Yingni Lin</dc:creator>
<dc:creator>Yong Li</dc:creator>
<dc:creator>Shijun Chen</dc:creator>
<dc:creator>Lina Zhou</dc:creator>
<dc:creator>Hejie Song</dc:creator>
<dc:creator>Cuiping Yang</dc:creator>
<dc:creator>Haiqing Zhang</dc:creator>
<dc:creator>Jianping Zhou</dc:creator>
<dc:creator>Shunchang Sun</dc:creator>
<dc:creator>Yanan Li</dc:creator>
<dc:creator>Juan Chen</dc:creator>
<dc:creator>Ruixue Feng</dc:creator>
<dc:creator>Niu Qiao</dc:creator>
<dc:creator>Yinyin Xie</dc:creator>
<dc:creator>Ruihong Zhang</dc:creator>
<dc:creator>Tong Yin</dc:creator>
<dc:creator>Saijuan Chen</dc:creator>
<dc:creator>Qingyun Li</dc:creator>
<dc:creator>Jiang Zhu</dc:creator>
<dc:creator>Jieming Qu</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine</dc:title>
<dc:identifier>pmid:37769658</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.033</dc:identifier>
</item>
<item>
<title>The local microenvironment drives activation of neutrophils in human brain tumors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769657/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231001160737&amp;v=2.17.9.post6+86293ac
      <description>Neutrophils are abundant immune cells in the circulation and frequently infiltrate tumors in substantial numbers. However, their precise functions in different cancer types remain incompletely understood, including in the brain microenvironment. We therefore investigated neutrophils in tumor tissue of glioma and brain metastasis patients, with matched peripheral blood, and herein describe the first in-depth analysis of neutrophil phenotypes and functions in these tissues. Orthogonal profiling...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 23:S0092-8674(23)00977-7. doi: 10.1016/j.cell.2023.08.043. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neutrophils are abundant immune cells in the circulation and frequently infiltrate tumors in substantial numbers. However, their precise functions in different cancer types remain incompletely understood, including in the brain microenvironment. We therefore investigated neutrophils in tumor tissue of glioma and brain metastasis patients, with matched peripheral blood, and herein describe the first in-depth analysis of neutrophil phenotypes and functions in these tissues. Orthogonal profiling strategies in humans and mice revealed that brain tumor-associated neutrophils (TANs) differ significantly from blood neutrophils and have a prolonged lifespan and immune-suppressive and pro-angiogenic capacity. TANs exhibit a distinct inflammatory signature, driven by a combination of soluble inflammatory mediators including tumor necrosis factor alpha (TNF-ɑ) and Ceruloplasmin, which is more pronounced in TANs from brain metastasis versus glioma. Myeloid cells, including tumor-associated macrophages, emerge at the core of this network of pro-inflammatory mediators, supporting the concept of a critical myeloid niche regulating overall immune suppression in human brain tumors.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769657/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231001160737&v=2.17.9.post6+86293ac">37769657</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.043>10.1016/j.cell.2023.08.043</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769657</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Roeltje R Maas</dc:creator>
<dc:creator>Klara Soukup</dc:creator>
<dc:creator>Nadine Fournier</dc:creator>
<dc:creator>Matteo Massara</dc:creator>
<dc:creator>Sabine Galland</dc:creator>
<dc:creator>Mara Kornete</dc:creator>
<dc:creator>Vladimir Wischnewski</dc:creator>
<dc:creator>Joao Lourenco</dc:creator>
<dc:creator>Davide Croci</dc:creator>
<dc:creator>Ángel F Álvarez-Prado</dc:creator>
<dc:creator>Damien N Marie</dc:creator>
<dc:creator>Johanna Lilja</dc:creator>
<dc:creator>Rachel Marcone</dc:creator>
<dc:creator>Gabriel F Calvo</dc:creator>
<dc:creator>Rui Santalla Mendez</dc:creator>
<dc:creator>Pauline Aubel</dc:creator>
<dc:creator>Leire Bejarano</dc:creator>
<dc:creator>Pratyaksha Wirapati</dc:creator>
<dc:creator>Iván Ballesteros</dc:creator>
<dc:creator>Andrés Hidalgo</dc:creator>
<dc:creator>Andreas F Hottinger</dc:creator>
<dc:creator>Jean-Philippe Brouland</dc:creator>
<dc:creator>Roy T Daniel</dc:creator>
<dc:creator>Monika E Hegi</dc:creator>
<dc:creator>Johanna A Joyce</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The local microenvironment drives activation of neutrophils in human brain tumors</dc:title>
<dc:identifier>pmid:37769657</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.043</dc:identifier>
</item>





























</channel>
</rss>